Utah Code 58-17b-625. Administration of a long-acting injectable and naloxone

58-17b-625. Administration of a long-acting injectable and naloxone.

(1)	A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).

Terms Used In Utah Code 58-17b-625

board: means the Utah State Board of Pharmacy created in Section 58-17b-201. See Utah Code 58-17b-102
Drug: means :

(i)

a substance recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;

(ii)	a substance that is required by any applicable federal or state law or rule to be dispensed by prescription only or is restricted to administration by practitioners only;

(iii)

a substance other than food intended to affect the structure or any function of the body of humans or other animals; and

(iv)

substances intended for use as a component of any substance specified in Subsections (26)(a)(i), (ii), (iii), and (iv). See Utah Code 58-17b-102

Pharmacist: means an individual licensed by this state to engage in the practice of pharmacy. See Utah Code 58-17b-102

Pharmacy: means any place where:

(a)	drugs are dispensed;

(b)	pharmaceutical care is provided;

(c)	drugs are processed or handled for eventual use by a patient; or

(d)

drugs are used for the purpose of analysis or research. See Utah Code 58-17b-102

Prescription: means an order issued:

(a)	by a licensed practitioner in the course of that practitioner's professional practice or by collaborative pharmacy practice agreement; and

(b)

for a controlled substance or other prescription drug or device for use by a patient or an animal. See Utah Code 58-17b-102

(2)

Notwithstanding the provisions of Subsection 58-17b-102(58)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Physicians Licensing Board created in Section 58-67-201, and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.

(3)

A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:

(a)	completes the training described in Subsection (2);

(b)	administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; and

(c)	is directed by the physician, as that term is defined in Section 58-67-102 or Section 58-68-102, who issues the prescription to administer the drug.

Amended by Chapter 223, 2023 General Session

Previous section

Next section

Part 6 Contents